Pulike Biological Engineering, Inc. (SHA:603566)

SHA:603566 Revenue

Pulike Biological Engineering had revenue of 249.24M CNY in the quarter ending March 31, 2026, a decrease of -10.54%. This brings the company's revenue in the last twelve months to 1.06B, down -2.32% year-over-year. In the year 2025, Pulike Biological Engineering had annual revenue of 1.09B with 4.54% growth.

• Revenue (ttm): 1.06B
• Revenue Growth: -2.32%
• P/S Ratio: 3.74
• Revenue / Employee: 683.75K
• Employees: 1,551
• Market Cap: 3.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.09B	47.32M	4.54%
Dec 31, 2024	1.04B	-210.13M	-16.77%
Dec 31, 2023	1.25B	22.62M	1.84%
Dec 31, 2022	1.23B	131.50M	11.97%
Dec 31, 2021	1.10B	170.06M	18.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error